Analystreport

Aridis Pharmaceuticals Inc (NASDAQ: ARDS) is now covered by analysts at Maxim Group. They set a "buy" rating on the stock.

Aridis Pharmaceuticals Inc.  (ARDS) 
Last aridis pharmaceuticals inc. earnings: 11/13 04:05 pm Check Earnings Report